Neurociencia del consumo y dependencia de sustancias psicoactivas

6. TRASTORNOS CONCURRENTES
Mansvelder HD, McGehee DS (2000) Long-term potentiation of excitatory
inputs to brain reward areas by nicotine. Neuron, 27:349–357.
Marder SR, Wirshing WC, Van Putten T (1991) Drug treatment of schizophrenia:
overview of recent research. Schizophrenia Research, 4:81–90.
Markou A, Kosten TR, Koob GF (1998) Neurobiological similarities in depression
and drug dependence: a self-medication hypothesis. Neuropsychopharmacology,
18:135–174.
Markou A y colab. (1993) Animal models of drug craving. Psychopharmacology,
112:163–182.
Marshall DL, Redfern PH, Wonnacott S (1997) Presynaptic nicotinic modulation
of dopamine release in the three ascending pathways studied by in vivo
microdialysis: comparison of naïve and chronic nicotine-treated rats. Journal of
Neurochemistry, 68:1511–1519.
Mason BJ y colab. (1996) A double-blind, placebo-controlled trial of
desipramine for primary alcohol dependence stratified on the presence or
absence of major depression. Journal of the American Medical Association,
275:761–767.
Masterson E, O’Shea B (1984) Smoking and malignancy in schizophrenia.
British Journal of Psychiatry, 145:429–432.
Mauskopf JA y colab. (1999) Annual health outcomes and treatment costs for
schizophrenia populations. Journal of Clinical Psychiatry, 60 Suppl: S14–S19.
Meltzer HY (1999) Outcome in schizophrenia: beyond symptom reduction.
Journal of Clinical Psychiatry, 60 Suppl: S3–S7.
Meltzer HY, Park S, Kessler R (1999) Cognition, schizophrenia, and the atypical
antipsychotic drugs. Proceedings of the National Academy of Sciences of the
United States of America, 96:13 591–13 593.
Menza MA y colab. (1991) Smoking and movement disorders in psychiatric
patients. Biological Psychiatry, 30:109–115.
Merlo Pich E y colab. (1995) Increase of extracellular corticotropin-releasing factor-like
immunoreactivity levels in the amygdala of awake rats during restraint
stress and ethanol withdrawal as measured by microdialysis. Journal of
Neuroscience, 15:5439–5447.
Miller HL y colab. (1996a) Clinical and biochemical effects of catecholamine
depletion on antidepressant-induced remission of depression. Archives of General
Psychiatry, 53:117–128.
Miller NS y colab. (1996b) Prevalence of depression and alcohol and other drug
dependence in addictions treatment populations. Journal of Psychoactive Drugs,
28:111–124.
Mittleman G, Bratt AM, Chase R (1998) Heterogeneity of the hippocampus:
effects of subfield lesions on locomotion elicited by dopaminergic agonists.
Behavioural Brain Research, 92:31–45.
Mogenson GJ, Jones DL, Yim CY (1980) From motivation to action: functional
interface between the limbic system and the motor system. Progress in
Neurobiology, 14:69–97.
201